• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种可磁共振追踪的治疗性纳米疫苗,可预防癌症肝转移。

An MRI-trackable therapeutic nanovaccine preventing cancer liver metastasis.

机构信息

Key Laboratory of Biomass Chemical Engineering of Ministry of Education, Center for Bionanoengineering, And College of Chemical and Biological Engineering, Zhejiang University, Hangzhou, Zhejiang, 310027, China; Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.

Key Laboratory of Biomass Chemical Engineering of Ministry of Education, Center for Bionanoengineering, And College of Chemical and Biological Engineering, Zhejiang University, Hangzhou, Zhejiang, 310027, China.

出版信息

Biomaterials. 2021 Jul;274:120893. doi: 10.1016/j.biomaterials.2021.120893. Epub 2021 May 19.

DOI:10.1016/j.biomaterials.2021.120893
PMID:34029913
Abstract

Cancer vaccines consisting of tumor-associated antigens (TAAs) can initiate a powerful antitumor immune response through antigen-presenting cells, such as dendritic cells (DCs) and macrophages, and have shown great potential in cancer prevention and therapy. However, poor anticancer efficacy and an uncertain immunization process have hitherto limited the application of cancer vaccines. Herein, a multifunctional nanovaccine comprising ovalbumin (OVA), MnO, and polydopamine (OMPN) was prepared by a facile one-pot method. OMPN displayed excellent anticancer efficacy against an orthotopic melanoma and could also prevent liver metastasis in a tumor re-challenge mice model. Additionally, the migration behavior of DCs in the inguinal lymph node after vaccination was tracked by MRI contrasted with OMPN, indicating successful DC activation and immune response. The superior anticancer efficacy, especially the high efficiency against tumor metastasis, and the capability of tracking the immunization process make OMPN a very promising multifunctional nanovaccine for cancer therapy.

摘要

癌症疫苗由肿瘤相关抗原(TAAs)组成,可以通过抗原呈递细胞(如树突状细胞和巨噬细胞)引发强大的抗肿瘤免疫反应,在癌症预防和治疗方面具有巨大潜力。然而,抗癌疗效不佳和免疫接种过程不确定,迄今为止限制了癌症疫苗的应用。本文通过简便的一锅法制备了包含卵清蛋白(OVA)、MnO 和聚多巴胺(OMPN)的多功能纳米疫苗。OMPN 对原位黑色素瘤具有优异的抗癌疗效,并且可以在肿瘤再挑战小鼠模型中预防肝转移。此外,通过 MRI 对比 OMPN 对接种后腹股沟淋巴结中 DC 迁移行为进行了跟踪,表明 DC 成功激活和免疫反应。优异的抗癌疗效,尤其是对肿瘤转移的高效性,以及跟踪免疫接种过程的能力,使 OMPN 成为一种很有前途的多功能纳米癌症治疗疫苗。

相似文献

1
An MRI-trackable therapeutic nanovaccine preventing cancer liver metastasis.一种可磁共振追踪的治疗性纳米疫苗,可预防癌症肝转移。
Biomaterials. 2021 Jul;274:120893. doi: 10.1016/j.biomaterials.2021.120893. Epub 2021 May 19.
2
Facile preparation of a metal-phenolic network-based lymph node targeting nanovaccine for antitumor immunotherapy.基于金属-酚醛网络的用于抗肿瘤免疫治疗的淋巴结靶向纳米疫苗的简便制备。
Acta Biomater. 2023 Mar 1;158:510-524. doi: 10.1016/j.actbio.2022.12.066. Epub 2023 Jan 2.
3
Manganese oxide-constructed multifunctional biomimetic nanovaccine for robust tumor-specific T cell priming and chemodynamic therapy.基于氧化锰的多功能仿生纳米疫苗用于增强肿瘤特异性 T 细胞的免疫原性和化学动力学治疗
Biomaterials. 2024 Sep;309:122626. doi: 10.1016/j.biomaterials.2024.122626. Epub 2024 May 20.
4
Liposomes-coated gold nanocages with antigens and adjuvants targeted delivery to dendritic cells for enhancing antitumor immune response.载有抗原和佐剂的脂质体包覆的金纳米笼靶向递送至树突状细胞,增强抗肿瘤免疫反应。
Biomaterials. 2017 Dec;149:41-50. doi: 10.1016/j.biomaterials.2017.09.029. Epub 2017 Sep 26.
5
Antigen-Directed Fabrication of a Multifunctional Nanovaccine with Ultrahigh Antigen Loading Efficiency for Tumor Photothermal-Immunotherapy.抗原导向构建多功能纳疫苗,用于肿瘤光热免疫治疗,具有超高抗原加载效率。
Adv Mater. 2018 Feb;30(8). doi: 10.1002/adma.201704408. Epub 2018 Jan 10.
6
Construction of lymph nodes-targeting tumor vaccines by using the principle of DNA base complementary pairing to enhance anti-tumor cellular immune response.利用 DNA 碱基互补配对原则构建淋巴结靶向肿瘤疫苗以增强抗肿瘤细胞免疫应答。
J Nanobiotechnology. 2024 May 8;22(1):230. doi: 10.1186/s12951-024-02498-1.
7
Engineering ApoE3-incorporated biomimetic nanoparticle for efficient vaccine delivery to dendritic cells via macropinocytosis to enhance cancer immunotherapy.工程化载有载脂蛋白E3的仿生纳米颗粒,通过巨胞饮作用将疫苗高效递送至树突状细胞,以增强癌症免疫治疗。
Biomaterials. 2020 Mar;235:119795. doi: 10.1016/j.biomaterials.2020.119795. Epub 2020 Jan 16.
8
Orchestrated Cytosolic Delivery of Antigen and Adjuvant by Manganese Ion-Coordinated Nanovaccine for Enhanced Cancer Immunotherapy.锰离子配位纳米疫苗介导的抗原和佐剂的细胞溶质共递用于增强癌症免疫治疗。
Nano Lett. 2023 Mar 8;23(5):1904-1913. doi: 10.1021/acs.nanolett.2c04970. Epub 2023 Feb 21.
9
Elastic Nanovaccine Enhances Dendritic Cell-Mediated Tumor Immunotherapy.弹性纳米疫苗增强树突状细胞介导的肿瘤免疫治疗。
Small. 2022 Aug;18(32):e2201108. doi: 10.1002/smll.202201108. Epub 2022 Jun 22.
10
Nanovaccine based on a protein-delivering dendrimer for effective antigen cross-presentation and cancer immunotherapy.基于递药树枝状大分子的纳米疫苗用于有效的抗原交叉呈递和癌症免疫治疗。
Biomaterials. 2019 Jul;207:1-9. doi: 10.1016/j.biomaterials.2019.03.037. Epub 2019 Mar 25.

引用本文的文献

1
Recent Advancement in MRI-Based Nanotheranostic Agents for Tumor Diagnosis and Therapy Integration.基于磁共振成像的肿瘤诊断与治疗一体化纳米诊疗剂的最新进展
Int J Nanomedicine. 2025 Aug 29;20:10503-10540. doi: 10.2147/IJN.S529003. eCollection 2025.
2
Invasion and metastasis in cancer: molecular insights and therapeutic targets.癌症中的侵袭与转移:分子见解与治疗靶点
Signal Transduct Target Ther. 2025 Feb 21;10(1):57. doi: 10.1038/s41392-025-02148-4.
3
Personalized nanovaccines for treating solid cancer metastases.用于治疗实体癌转移的个体化纳米疫苗。
J Hematol Oncol. 2024 Nov 28;17(1):115. doi: 10.1186/s13045-024-01628-4.
4
Manganese-derived biomaterials for tumor diagnosis and therapy.锰基生物材料在肿瘤诊断与治疗中的应用
J Nanobiotechnology. 2024 Jun 15;22(1):335. doi: 10.1186/s12951-024-02629-8.
5
Interventional hydrogel microsphere vaccine as an immune amplifier for activated antitumour immunity after ablation therapy.介入性水凝胶微球疫苗作为消融治疗后激活抗肿瘤免疫的免疫增强剂。
Nat Commun. 2023 Jul 11;14(1):4106. doi: 10.1038/s41467-023-39759-w.
6
The use of RNA-based treatments in the field of cancer immunotherapy.基于 RNA 的治疗方法在癌症免疫治疗领域的应用。
Mol Cancer. 2023 Jul 7;22(1):106. doi: 10.1186/s12943-023-01807-w.
7
Targeting lymph node delivery with nanovaccines for cancer immunotherapy: recent advances and future directions.纳米疫苗靶向淋巴结递呈用于癌症免疫治疗:最新进展和未来方向。
J Nanobiotechnology. 2023 Jul 7;21(1):212. doi: 10.1186/s12951-023-01977-1.
8
Instigation of the epoch of nanovaccines in cancer immunotherapy.纳米疫苗在癌症免疫治疗新纪元中的激发作用。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 May-Jun;15(3):e1870. doi: 10.1002/wnan.1870. Epub 2022 Nov 21.
9
Nanovaccines for Cancer Prevention and Immunotherapy: An Update Review.用于癌症预防和免疫治疗的纳米疫苗:最新综述
Cancers (Basel). 2022 Aug 9;14(16):3842. doi: 10.3390/cancers14163842.